PIDTC: Hematopoietic Stem Cell Transplantation Using Carrier Donors for CD40L Deficiency Results in Excellent Outcomes
7 set 2022 ·
1 min. 54 sec.
Iscriviti gratuitamente
Ascolta questo episodio e molti altri. Goditi i migliori podcast su Spreaker!
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the journal Blood Advances on June 28, 2022, titled "HSCT using...
mostra di più
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the journal Blood Advances on June 28, 2022, titled "HSCT using carrier donors for CD40L deficiency results in excellent immune function and higher CD40L expression in cTfh."
Read the paper here: https://ashpublications.org/bloodadvances/article/6/12/3751/485000/HSCT-using-carrier-donors-for-CD40L-deficiency
Learn more about PIDTC: https://www1.rarediseasesnetwork.org/cms/pidtc
mostra meno
Read the paper here: https://ashpublications.org/bloodadvances/article/6/12/3751/485000/HSCT-using-carrier-donors-for-CD40L-deficiency
Learn more about PIDTC: https://www1.rarediseasesnetwork.org/cms/pidtc
Informazioni
| Autore | RDCRN |
| Organizzazione | RDCRN |
| Sito | - |
| Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
